Cardiovascular and gastrointestinal consequences of discontinuation with low-dose acetylsalicylic acid therapy in patients with cardiovascular disease

被引：0
|
作者：
Garcia Rodriguez, L. A. [1 ]
Cea Soriano, L. [1 ]
Bueno, H. [2 ]
Lanas, A. [3 ]
Johansson, S. [4 ]
机构：
[1] Ctr Espanol Invest Farmacoepidemiol CEIFE, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain
[3] Univ Hosp, CIBERehd, Zaragoza, Spain
[4] AstraZeneca R&D, Molndal, Sweden
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 495
页数：1
相关论文
共 50 条
  • [11] Low-Dose Aspirin Therapy for Cardiovascular PreventionQuantification and Consequences of Poor Compliance or Discontinuation
    Johan Herlitz
    Peter P. Tóth
    Jørgen Næsdal
    American Journal of Cardiovascular Drugs, 2010, 10 : 125 - 141
  • [12] Low-dose acetylsalicylic acid and upper gastrointestinal bleeding in primary and secondary cardiovascular disease prevention populations
    Lin, K. J.
    De Caterina, R.
    Garcia Rodriguez, L. A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 437 - 437
  • [13] UPPER GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH CARDIOVASCULAR RISK TAKING LOW-DOSE ACETYLSALICYLIC ACID: AN OBSERVATIONAL STUDY
    Sorstadius, E.
    Thompson, V. J.
    Pratt, S. E.
    Delgado, J. P.
    Elkin, E.
    Naucler, E.
    Naesdal, J.
    Junghard, O.
    VALUE IN HEALTH, 2009, 12 (07) : A339 - A339
  • [14] Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid A Quantitative Study in Patients with Cardiovascular Risk
    Moberg, Christina
    Naesdal, Jorgen
    Svedberg, Lars-Erik
    Duchateau, Delphine
    Harte, Nicola
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2011, 4 (02): : 103 - 113
  • [15] Low-Dose Aspirin Therapy for Cardiovascular Prevention Quantification and Consequences of Poor Compliance or Discontinuation
    Herlitz, Johan
    Toth, Peter P.
    Naesdal, Jorgen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (02) : 125 - 141
  • [16] Risk of cardiovascular outcomes after low-dose acetylsalicylic acid discontinuation: a UK primary care study
    Cea-Soriano, L.
    Garcia Rodriguez, L. A.
    Johansson, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 484 - 484
  • [17] Gastrointestinal adverse events compromise adherence to low-dose acetylsalicylic acid: a quantitative study in patients with cardiovascular risk
    Moberg, Christina
    Naesdal, Jorgen
    Svedberg, Lars Erik
    Duchateau, Delphine
    Harte, Nicola
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 47 - 47
  • [18] Discontinuation of low-dose acetylsalicylic acid therapy increases the risk of stroke
    Darran Yates
    Nature Reviews Neurology, 2011, 7 (3) : 126 - 126
  • [19] Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease
    Lamotte, Mark
    Pinol, Carme
    Brotons, Carlos
    Annemans, Lieven
    Guardiola, Elena
    Evers, Thomas
    Kubin, Maria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (08): : 807 - 815
  • [20] Patient perspectives on gastrointestinal symptoms during use of low-dose acetylsalicylic acid for cardiovascular risk management
    Margolis, Mary Kay
    Sorstadius, Elisabeth
    Halling, Katarina
    Manson, Stephanie
    Coyne, Karin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 : 39 - 39
12345